Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

208

Citations

19

References

2011

Year

Michael Häggman, Walter M. Stadler, Jeffrey R. Gingrich, Vasileios J. Assikis, Anders Björk, Örjan Nordle, G. Forsberg, Michael A. Carducci, Andrew J. Armstrong

Journal of Clinical Oncology

Abstract

TASQ significantly slowed progression and improved PFS in patients with metastatic CRPC with an acceptable AE profile.

References

	Year	Citations

Page 1